These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25867045)

  • 21. Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B.
    Tsukimoto M; Nagaoka M; Shishido Y; Fujimoto J; Nishisaka F; Matsumoto S; Harunari E; Imada C; Matsuzaki T
    J Nat Prod; 2011 Nov; 74(11):2329-31. PubMed ID: 22035372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis.
    Crews CM; Lane WS; Schreiber SL
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4316-9. PubMed ID: 8633062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of protein synthesis inhibition by didemnin B in vitro.
    SirDeshpande BV; Toogood PL
    Biochemistry; 1995 Jul; 34(28):9177-84. PubMed ID: 7619818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of didemnin B, a depsipeptide from the sea.
    Li LH; Timmins LG; Wallace TL; Krueger WC; Prairie MD; Im WB
    Cancer Lett; 1984 Jul; 23(3):279-88. PubMed ID: 6744252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
    Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
    Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feedback loops blockade potentiates apoptosis induction and antitumor activity of a novel AKT inhibitor DC120 in human liver cancer.
    Yang F; Deng R; Qian XJ; Chang SH; Wu XQ; Qin J; Feng GK; Ding K; Zhu XF
    Cell Death Dis; 2014 Mar; 5(3):e1114. PubMed ID: 24625973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Antimalarials and Antineoplastic Drugs can Interact in Combination Therapies: A Perspective on the Role of PPT1 Enzyme.
    Duarte D; Vale N
    Curr Drug Metab; 2021; 22(13):1009-1016. PubMed ID: 34791996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma.
    Slotkin EK; Patwardhan PP; Vasudeva SD; de Stanchina E; Tap WD; Schwartz GK
    Mol Cancer Ther; 2015 Feb; 14(2):395-406. PubMed ID: 25519700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex.
    Carelli JD; Sethofer SG; Smith GA; Miller HR; Simard JL; Merrick WC; Jain RK; Ross NT; Taunton J
    Elife; 2015 Dec; 4():. PubMed ID: 26651998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687).
    Hochster H; Oratz R; Ettinger DS; Borden E
    Invest New Drugs; 1998-1999; 16(3):259-63. PubMed ID: 10360606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells.
    Losada A; Berlanga JJ; Molina-Guijarro JM; Jiménez-Ruiz A; Gago F; Avilés P; de Haro C; Martínez-Leal JF
    Biochem Pharmacol; 2020 Feb; 172():113744. PubMed ID: 31812675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib.
    Amin DN; Ruiz-Saenz A; Gulizia N; Moasser MM
    Oncotarget; 2015 Dec; 6(38):41123-33. PubMed ID: 26516700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy.
    García-García C; Ibrahim YH; Serra V; Calvo MT; Guzmán M; Grueso J; Aura C; Pérez J; Jessen K; Liu Y; Rommel C; Tabernero J; Baselga J; Scaltriti M
    Clin Cancer Res; 2012 May; 18(9):2603-12. PubMed ID: 22407832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma.
    Ezell SA; Mayo M; Bihani T; Tepsuporn S; Wang S; Passino M; Grosskurth SE; Collins M; Parmentier J; Reimer C; Byth KF
    Oncotarget; 2014 Jul; 5(13):4990-5001. PubMed ID: 24970801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.
    Zhang H; Berel D; Wang Y; Li P; Bhowmick NA; Figlin RA; Kim HL
    PLoS One; 2013; 8(1):e54918. PubMed ID: 23349989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An enzyme immunoassay for determining plasma concentrations of didemnin B.
    Raybould TJ; Grothaus PG; Simpson SB; Bignami GS; Lazo CB; Newman RA
    J Clin Lab Anal; 1992; 6(3):136-42. PubMed ID: 1506980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-translational regulation of mTOR complex 1 in hypoxia and reoxygenation.
    Tan CY; Hagen T
    Cell Signal; 2013 May; 25(5):1235-44. PubMed ID: 23416465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.